주식/증권
📈 긍정적
관련 뉴스
OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition
2026/08/12
Biostem raises 2026 revenue outlook to $26M-$29M while targeting manufacturing transfer in H1 2027
2026/08/12
Intellinetics expects double-digit SaaS growth for fiscal 2026 while outlining a 2-4 year shift toward recurring revenue
2026/08/12
Nortech outlines backlog strength with $93.8M total orders, as Q2 net sales rise 9.3% to $33.5M
2026/08/12